USMI Company Milestones

2024
2024

FDA Clearance

  • US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System
2023
2023

Patent Awarded for “System and Method for inducing Apoptosis in Cancer Cells”
  • Patent Awarded for “System and Method for inducing Apoptosis in Cancer Cells”
2022
2022

  • Initiated direct salesforce
  • Company raised $10.2 million in a private placement
2021
2021

  • Successfully completed phase 1 multi-center clinical trial using Canady Helios Cold Plasma for the treatment of cancer.
  • Published successful results of Canady Helios Cold Plasma used in conjunction with FOLFIRINOX chemotherapy drug.
  • Gained UL manufacturing site approval for production of XL-1000 generator.
Gained UL manufacturing site approval for production of XL-1000 generator.
2020
2020

Launched Canady Plasma XL-1000 Electrosurgical Generator
  • Launched Canady Plasma XL-1000 Electrosurgical Generator
  • Began Canady Helios Cold Plasma Phase 1 clinical trial
  • Canady Helios Cold Plasma HERO system treatment of COVID-19 collaboration with George Washington University
  • Canady Helios Cold Plasma used in compassionate treatment of inoperable retroperitoneal cancer
2019
2019

  • Obtained 510(k) clearance for Canady Plasma XL-1000 Electrosurgical Generator
  • FDA IDE approval for Canady Helios Cold Plasma Phase 1 clinical trial in the U.S.
  • Acquired Endocontrol, robotic surgical company with voice-operated robotics
Acquired Endocontrol, robotic surgical company with voice-operated robotics
2018
2018

  • U.S. patents granted for Canady Helios Cold Atmospheric Plasma
2017
2017

  • Canady Helios Cold Plasma and Hybrid Plasma Scalpels used in the first clinical liver tumor resection
2016
2016

Introduction of Paddle Blade for Canady Hybrid Plasma Scalpel
  • Introduction of Paddle Blade for Canady Hybrid Plasma Scalpel
2015
2015

Received FDA compassionate-use approval for solid tumors using Canady Helios Cold Plasma
  • Received FDA compassionate-use approval for solid tumors using Canady Helios Cold Plasma
2014
2014

  • Released the 2nd generation Canady Hybrid Plasma Scalpel
  • USMI designed and produced the world’s first cold plasma scalpel for cancer treatment.
2013
2013

The world’s first Commercial Cold Plasma Generator System
  • The world’s first Commercial Cold Plasma Generator System was developed at USMI, cold plasma research was accelerated
2012
2012

  • Patent for the Method to generate Cold Plasma was granted by US Patent Office
2011
2011

FDA approval of Canady Hybrid Plasma Scalpel, plasma generators & endoscope
  • FDA approval of Canady Hybrid Plasma Scalpel, plasma generators & endoscope
  • Launch of Cold Plasma Research Program
2009
2009

  • USPI/USMI founded by Jerome Canady, M.D., and partners
  • USPI entered into a technology transfer agreement with George Washington University (GWU) and John Hopkins University (JHU) for Cold Plasma.